Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROSHARES TRUST (ZBIO) Current Assets: 2023-2024

Historic Current Assets for Zenas BioPharma (ZBIO) over the last 2 years, with Dec 2024 value amounting to $355.9 million.

  • Zenas BioPharma's Current Assets fell 24.67% to $296.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $296.6 million, marking a year-over-year decrease of 24.67%. This contributed to the annual value of $355.9 million for FY2024, which is 495.15% up from last year.
  • Zenas BioPharma's Current Assets amounted to $355.9 million in FY2024, which was up 495.15% from $59.8 million recorded in FY2023.
  • Zenas BioPharma's Current Assets' 5-year high stood at $355.9 million during FY2024, with a 5-year trough of $59.8 million in FY2023.
  • In the last 2 years, Zenas BioPharma's Current Assets had a median value of $207.9 million in 2023 and averaged $207.9 million.
  • Data for Zenas BioPharma's Current Assets shows a peak YoY soared of 495.15% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Zenas BioPharma's Current Assets stood at $59.8 million in 2023, then soared by 495.15% to $355.9 million in 2024.